The company's asset efficiency, represented by a robust -2.919% return, is a testament to Lotus Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. Lotus Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.159%. Furthermore, the proficiency of Lotus Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable 0.149% return on capital employed.
Stock Prices
Lotus Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.0035, while its low point bottomed out at $0.0035. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Lotus Pharmaceuticals, Inc.'s stock market.
Liquidity Ratios
Analyzing LTUS liquidity ratios reveals its financial health of the firm.
The current ratio of 4.87% gauges short-term asset coverage for liabilities.
The quick ratio (1.63%) assesses immediate liquidity, while the cash ratio (1.63%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
4.87%
Quick Ratio
1.63%
Cash Ratio
1.63%
Profitability Ratios
The net income per EBT, 100.00%, and the EBT per EBIT, 100.04%, provide insights into its earnings hierarchy.
cards.indicator
cards.value
Net Income per EBT
100.00%
EBT per EBIT
100.04%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 0.05, it details the span from stock purchase to revenue.
cards.indicator
cards.value
Days of Sales Outstanding
2
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2053.92%, highlights its total liabilities relative to assets.
With a debt-equity ratio of -1.05, we discern the balance between debt and equity financing.
cards.indicator
cards.value
Debt Ratio
2053.92%
Debt Equity Ratio
-1.05
Total Debt to Capitalization
2053.92%
Cash Flow to Debt Ratio
-0.16
Company Equity Multiplier
-0.05
Growth Ratios
EBIT growth, 10.90%, and operating income growth, 10.90%, offer insights into operational profitability progression.
cards.indicator
cards.value
EBIT Growth
10.90%
Operating Income Growth
10.90%
Net Income Growth
10.88%
Operating Cash Flow Growth
19.67%
Free Cash Flow Growth
19.67%
10-Year Operating CF Growth per Share
9.21%
5-Year Operating CF Growth per Share
9.21%
3-Year Operating CF Growth per Share
-232.76%
10-Year Net Income Growth per Share
10.73%
5-Year Net Income Growth per Share
10.73%
3-Year Net Income Growth per Share
-227.19%
10-Year Shareholders Equity Growth per Share
-426.73%
5-Year Shareholders Equity Growth per Share
-426.73%
3-Year Shareholders Equity Growth per Share
-223.01%
Asset Growth
18.03%
Book Value per Share Growth
-20.41%
Debt Growth
20.54%
SGA Expenses Growth
-10.88%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 11,566,473.058, captures the company's total value, considering both debt and equity.
Income quality, 1.02, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
11,566,473.058
Income Quality
1.02
Return on Tangible Assets
-331.14%
Working Capital
-111,002
Tangible Asset Value
-111,002
Net Current Asset Value
-111,002
Invested Capital
-1
Average Payables
100
ROIC
-331.10%
ROE
0.17%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -97.34, and the price to book ratio, -97.34, reflect the market's valuation relative to the company's book value.
Ratios like price to free cash flows, -5.83, and price to operating cash flows, -564.76, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
-97.34
Price to Book Ratio
-97.34
Price Cash Flow Ratio
-564.76
Price Earnings to Growth Ratio
-3.83
Enterprise Value Multiple
0.20
Price Fair Value
-97.34
Price to Operating Cash Flow Ratio
-564.76
Price to Free Cash Flows Ratio
-5.83
Price to Tangible Book Ratio
-103.17
Enterprise Value Over EBITDA
-614.91
EV to Operating Cash Flow
-604.56
Earnings Yield
-0.16%
Free Cash Flow Yield
-0.17%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
